Flecainide — Discount Pricing
Flecainide is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Flecainide Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $86.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Flecainide
Flecainide is a prescription medication. Ask your doctor if Flecainide is right for you.
Other strengths and forms of Flecainide
How to Check Flecainide Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Flecainide at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
About Flecainide
Flecainide is a crucial medication prescribed to help manage certain serious heart rhythm disorders, often improving quality of life for those affected. At TheDrugClub, we understand the importance of consistent access to vital prescriptions. Our membership program is designed to help you navigate medication costs, potentially saving you a significant amount on essential drugs like flecainide.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Flecainide is approved for (FDA label)
In patients without structural heart disease, flecainide is indicated for the prevention of - paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms - paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms. Flecainide is also indicated for the prevention of - documented ventricular arrhythmias, such as sustained ventricular tachycardia ( sustained VT), that in the judgment of the physician, are life-threatening. Use of flecainide for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic.
Source: Read the full FDA label on DailyMed. Label effective date: June 11, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Flecainide (FDA label)
In post-myocardial infarction patients with asymptomatic PVCs and nonsustained ventricular tachycardia, flecainide therapy was found to be associated with a 5.1% rate of death and non-fatal cardiac arrest, compared with a 2.3% rate in a matched placebo group (see WARNINGS ).
Source: FDA prescribing information (DailyMed). Set ID: ee9595d5-08a1-4529-9215-ddc3c7f929c4. SPL document ID: e9e0eab5-efc5-4bac-8d46-0bce60b2fcc5. Label effective date: June 11, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.